A detailed history of Exchange Traded Concepts, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 5,793 shares of GKOS stock, worth $859,449. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,793
Holding current value
$859,449
% of portfolio
0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$113.62 - $135.39 $658,200 - $784,314
5,793 New
5,793 $754,000
Q4 2022

Jan 17, 2023

BUY
$40.82 - $57.75 $68,332 - $96,673
1,674 Added 6.07%
29,253 $1.28 Million
Q3 2022

Oct 07, 2022

SELL
$46.84 - $58.49 $612,198 - $764,464
-13,070 Reduced 32.15%
27,579 $1.47 Million
Q2 2022

Jul 20, 2022

SELL
$34.86 - $63.77 $10,423 - $19,067
-299 Reduced 0.73%
40,649 $1.85 Million
Q1 2022

Apr 26, 2022

SELL
$44.33 - $57.82 $1.86 Million - $2.43 Million
-41,964 Reduced 50.61%
40,948 $2.37 Million
Q4 2021

Jan 13, 2022

BUY
$40.27 - $56.99 $422,472 - $597,882
10,491 Added 14.49%
82,912 $3.69 Million
Q3 2021

Oct 18, 2021

BUY
$47.43 - $84.23 $1.36 Million - $2.41 Million
28,579 Added 65.19%
72,421 $3.49 Million
Q2 2021

Jul 30, 2021

BUY
$73.06 - $97.7 $687,348 - $919,161
9,408 Added 27.32%
43,842 $3.72 Million
Q1 2021

Apr 20, 2021

BUY
$70.43 - $97.42 $681,480 - $942,635
9,676 Added 39.08%
34,434 $2.89 Million
Q4 2020

Jan 19, 2021

BUY
$48.9 - $75.26 $528,022 - $812,657
10,798 Added 77.35%
24,758 $1.86 Million
Q3 2020

Oct 30, 2020

BUY
$37.23 - $50.97 $221,034 - $302,608
5,937 Added 74.0%
13,960 $691,000
Q2 2020

Jul 15, 2020

BUY
$28.78 - $46.83 $113,824 - $185,212
3,955 Added 97.22%
8,023 $308,000
Q1 2020

Apr 14, 2020

BUY
$25.53 - $70.14 $63,339 - $174,017
2,481 Added 156.33%
4,068 $126,000
Q4 2019

Jan 22, 2020

BUY
$54.18 - $65.64 $85,983 - $104,170
1,587 New
1,587 $86,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.06B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.